Clinical Trials Arena on MSN
ESMO26: Clinical progress shifts a historically difficult pancreatic cancer landscape
Revolution Medicines’ impressive daraxonrasib data has spurred hope in the pancreatic cancer space.
Ionis Pharmaceuticals, Inc. is a long-term buy as launches, royalties, & pipeline growth boost revenue prospects despite cash ...
A deeply personal family experience inspired a historic donation that could change the future of breast cancer research.
Unexplained fatigue, muscle weakness and vision problems can be among the signs of a deficiency in vitamin E, a nutrient that often gets little attention. Experts warn that while this deficiency is ...
ORR at 6mg/kg dose in late-line CRC patients ARR-217 was generally well-tolerated ArriVent to host virtual webinar on Monday, October 26, ...
Pre-specified and Statistically Powered Key Endpoints Included Progression-free Survival (PFS) and Overall Survival (OS). Although Primary ...
By Bhanvi Satija MADRID, Oct 25 (Reuters) - Takeda Pharmaceutical plans to seek regulatory approval in Japan next year for ...
Some cancer cells may survive chemotherapy by entering a zombie-like state that helps them avoid death and recruit support ...
Yard ornaments and amusing pet costumes for Halloween are good fun for humans, but they may cause a scare for pets. The National Retail Federation predicts consumers will spend more than $13 billion ...
Since its premiere in 2005, the hit medical drama 'Grey's Anatomy' has captivated audiences with high-stakes hospital ...
A US government-commissioned study estimated that consuming 14 alcoholic drinks a week is linked to a lifetime ...
NovaBridge Biosciences Reports Mature Phase 1b Givastomig Data Supporting Registrational Development
NovaBridge Biosciences announced updated results from the Phase 1b study of givastomig, a bispecific antibody targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results